ACIU Research and Charts

ACIU - AC Immune SA (Healthcare: Biotechnology)

Projected Earnings Date: 2024-07-30 (Delayed quote data 2025-05-09)

Last 1.68	Change ⇑ +0.02 (+1.20%)	Volume 69,059
	Open 1.68	High 1.70	Low 1.66

8EMA (Daily) 1.67	40EMA (Daily) 1.81	50EMA (Daily) 1.89	STO (Daily) 65.265	MACD Hist (Daily) 0.050
8EMA (Weekly) 1.799	40EMA (Weekly) 2.57	50EMA (Weekly) 2.67	STO (Weekly) 12.834	MACD Hist (Weekly) -0.102


Company Profile
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.